Directo Funding: How Much Did They Raise & Key Investors

How Much Did Directo Raise?
Funding & Key Investors

Directo, the Melbourne-based B2B e-commerce pharmacy marketplace, has successfully secured a significant capital injection, bringing its total funding to $4.3M. This latest strategic investment of $2M underscores the company's robust growth trajectory within the digital health and pharmaceutical supply chain sectors. By consolidating its market position, Directo continues to demonstrate the scalability of its platform, attracting substantial interest from institutional backers and strategic partners alike.

The recent financing round marks a pivotal moment for the organization, transitioning from its early-stage roots to a mature enterprise-level operation. This influx of capital is expected to accelerate the deployment of its marketplace infrastructure, further bridging the gap between pharmaceutical manufacturers and retail pharmacy outlets across the Australian market.

What is Directo?

Directo

Software

Content & Collaboration Software

Founded in 2018, Directo operates as a specialized B2B e-commerce marketplace designed to streamline the procurement processes for the pharmacy industry. By digitizing the traditional supply chain, the platform provides a centralized hub for inventory management, order fulfillment, and price transparency. Its market position is defined by its ability to reduce operational friction for pharmacists while providing manufacturers with direct access to a fragmented retail landscape. As a key player in the Australian health-tech ecosystem, Directo leverages data-driven insights to optimize stock availability and improve the efficiency of pharmaceutical distribution networks.

How much funding has Directo raised?

Directo has raised a total of $4.3M across 2 funding rounds:

2022

Angel/Seed

$2.3M

2024

Share Placement

$2M

Angel/Seed (2022): $2.3M with participation from Investible

Share Placement (2024): $2M, investors not publicly disclosed

Key Investors in Directo

Investible

A prominent early-stage venture capital firm that focuses on backing high-potential startups with scalable technology solutions.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Directo?

With the successful closure of this major strategic investment, Directo is well-positioned to scale its operations and potentially expand its footprint beyond its current regional focus. The company is expected to prioritize the enhancement of its proprietary marketplace technology, focusing on predictive analytics and automated logistics to further differentiate its service offering. As the B2B e-commerce sector continues to mature, Directo's ability to maintain its competitive edge will depend on its capacity to integrate deeper into the existing pharmaceutical supply chain. Future growth initiatives will likely involve strategic partnerships with major wholesalers and the expansion of its service suite to include advanced financial tools for pharmacy procurement, ensuring long-term sustainability and market dominance.

See full Directo company page

See More Financial Insights